/ADVT

ADVT Stock - Advantis Corp.

Q: What is the analyst price target for ADVT?

Analyst price target information is not currently available for ADVT.

Q: What is ADVT's market cap?

Market capitalization information is not currently available for ADVT.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for ADVT

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY1999

FY2015

FY2016

FY2017

FY2018

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.83

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2018	FY2017	FY2016	FY2015	FY1999
Revenue	$826,990	$406,205	$46,337	$36,820	$1.74M
Gross Profit	$762,941	$292,685	$26,909	$15,000	$114,052
Gross Margin	92.3%	72.1%	58.1%	40.7%	6.6%
Operating Income	$-22,970	$-113,070	$-217,420	$-239,880	$-2,651,239
Net Income	$-23,644	$-113,685	$-106,088	$108,588	$-2,714,803
Net Margin	-2.9%	-28.0%	-228.9%	294.9%	-156.4%
EPS	$-0.00	$-0.00	$-0.00	$0.00	$0.00

Company Overview

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.

Visit Website

Frequently Asked Questions about ADVT

What is ADVT's current stock price?

Advantis Corp. (ADVT) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for ADVT?

No analyst price targets are currently available for this stock.

What sector is Advantis Corp. in?

Advantis Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is ADVT's market cap?

Advantis Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does ADVT pay dividends?

No, Advantis Corp. does not currently pay a dividend to shareholders.